PDS Biotechnology

-$0.12 (-0.99%) As of 4:22 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PDSB and other ETFs, options, and stocks.

About PDSB

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection.

CEO
Frank K. Bedu-Addo
Employees
15
Headquarters
Princeton, New Jersey
Founded
2005

PDSB Key Statistics

Market Cap
325.88M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
462.52K
High Today
$11.59
Low Today
$11.04
Open Price
$11.59
Volume
231.73K
52 Week High
$17.85
52 Week Low
$1.87

PDSB Earnings

-$0.39
-$0.26
-$0.13
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
-$0.20 per share
Actual
Available Nov 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure